Atherosclerosis, an accumulation of fat and inflammation in arteries, causes myocardial infarction and stroke, two deadly complications. The risk factors for atherosclerosis are well known and include hypercholesterolemia, smoking, diabetes and high blood pressure. Protective factors may also be important in atherosclerosis but are poorly understood. A new study published in this month´s issue of Nature Medicine presents the discovery of such a protective mechanism, which could be of great importance for future therapy.
A collaborative effort organized within the European Vascular Genomics Network (EVGN) has identified a subpopulation of T lymphocytes (called natural T regulatory cells, or Treg), which inhibit the formation of atherosclerotic plaques. Drs. Alain Tedgui and Ziad Mallat of INSERM U689 in Paris and Dr. Goran Hansson of Karolinska Institute´s Center for Molecular Medicine in Stockholm led two of the research teams in the study.
The senior author of the study Dr. Ziad Mallat explains the theory behind the study: “We postulated that in atherosclerosis there is an imbalance between regulatory and pathogenic immunity, and that such a disequilibrium promotes both plaque development and plaque inflammation”.
“We tested our hypothesis in a mouse model of the human disease, explains Mallat. “If these Treg were absent, the animals developed bigger atherosclerotic lesions. But when we injected the Treg cells they could turn off the atherosclerotic process”.
A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences